Statistics for Krystal Biotech (id:6430 KRYS)

Valuation metrics

Market cap

5.38B

Enterprise value

5.05B

Trailing P/E (ttm)

105.18

Forward P/E

32.00

PEG ratio

32.00

Price/Sales (ttm)

22.29

Price/Book (mrq)

6.08

Enterprise Value/Revenue

20.92

Enterprise Value/EBITDA

73.07

Overview

Shares outstanding

28.76M

Float

22.93M

Shares short

3.54M

% Held by insiders

0.12%

% Held by institutions

1.08%

Average volume (10 days)

342.17K

Average volume (90 days)

Price summary

52-Week low

99.00

52-Week high

219.34

52-Week change

45.97%

Beta

0.82

50-Day moving average

181.30

200-Day moving average

172.37

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

21.68%

Operating margin

41.67%

Operational effectiveness

Return on assets

4.58%

Return on equity

6.38%

Income statement

Revenue (ttm)

8.49

Revenue per share (ttm)

8.49

Quarterly revenue growth (yoy)

-0.66

Gross profit (ttm)

47.60M

EBITDA

220.17M

Net income to common (ttm)

52.37M

Diluted EPS (ttm)

1.78

Quarterly earnings growth (yoy)

-66.30%

Balance sheet

Total cash (mrq)

588.32M

Total cash per share (mrq)

20.46

Total debt (mrq)

7.48M

Total Debt/Equity (mrq)

0.84

Current ratio (mrq)

796.60%

Book value per share (mrq)

30.80

Cash flow

Cash flow statement

63.34M

Levered free cash flow (LFCF)

42.38M